Literature DB >> 25467165

Sodium houttuyfonate and EDTA-Na₂ in combination effectively inhibits Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans in vitro and in vivo.

Weifeng Huang1, Qiangjun Duan, Fang Li, Jing Shao, Huijuan Cheng, Daqiang Wu.   

Abstract

Sodium houttuyfonate (SH) has been found to be mildly anti-pathogenetic against the planktonic and biofilm phenotypes of Pseudomonas aeruginosa. Here, we have attempted to investigate further the anti-pathogenicity of SH and EDTA-Na₂ in combination and in vitro and in vivo against planktonic and biofilm phenotypes of Pseudomonas aeruginosa (16 strains), Staphylococcus aureus (13 strains) and Candida albicans (13 strains). The antimicrobial activity of SH against all three pathogens increased dramatically when it was combined with EDTA-Na₂, in vitro. Toxic reactions to the drugs when administered orally were insignificant in mice; no abnormalities were observed in the internal organs, such as the lungs and kidneys. Finally, the results of in vivo studies indicate that SH could extend the lifespan of infected animals when administered in combination with EDTA-Na2. Therefore, the results of the present study lead us to suggest that SH could be a promising antimicrobial agent and that SH combined with EDTA-Na₂ has the potential to be an excellent choice of drug for combating bacterial infections clinically.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25467165     DOI: 10.1016/j.bmcl.2014.10.072

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  7 in total

1.  Sodium houttuyfonate in vitro inhibits biofilm dispersion and expression of bdlA in Pseudomonas aeruginosa.

Authors:  Tianming Wang; Weifeng Huang; Qiangjun Duan; Jian Wang; Huijuan Cheng; Jing Shao; Fang Li; Daqiang Wu
Journal:  Mol Biol Rep       Date:  2018-12-03       Impact factor: 2.316

2.  Synergistic in vitro activity of sodium houttuyfonate with fluconazole against clinical Candida albicans strains under planktonic growing conditions.

Authors:  Jing Shao; YanYan Cui; MengXiang Zhang; TianMing Wang; DaQiang Wu; ChangZhong Wang
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

3.  Physical Interaction of Sodium Houttuyfonate With β-1,3-Glucan Evokes Candida albicans Cell Wall Remodeling.

Authors:  Wenyue Da; Jing Shao; Qianqian Li; Gaoxiang Shi; Tianming Wang; Daqiang Wu; Changzhong Wang
Journal:  Front Microbiol       Date:  2019-01-25       Impact factor: 5.640

4.  Sodium houttuyfonate enhances the mono-therapy of fluconazole on oropharyngeal candidiasis (OPC) through HIF-1α/IL-17 axis by inhibiting cAMP mediated filamentation in Candida albicans-Candida glabrata dual biofilms.

Authors:  Mengli Chen; Ting Cheng; Chen Xu; Min Pan; Jiadi Wu; Tianming Wang; Daqiang Wu; Guiming Yan; Changzhong Wang; Jing Shao
Journal:  Virulence       Date:  2022-12       Impact factor: 5.882

5.  Antifungal Activity of Sodium New Houttuyfonate Against Aspergillus fumigatus in vitro and in vivo.

Authors:  Qian Zhang; Fangyan Liu; Meng Zeng; Jinping Zhang; Yanfei Liu; Caiyan Xin; Yingyu Mao; Zhangyong Song
Journal:  Front Microbiol       Date:  2022-04-26       Impact factor: 6.064

6.  The Immune Change of the Lung and Bowel in an Ulcerative Colitis Rat Model and the Protective Effect of Sodium Houttuyfonate Combined With Matrine.

Authors:  Lulu Ni; Shan Jing; Li Zhu; Xue Yang; Xinyue Wang; Su Tu
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

Review 7.  The therapeutic potential of Houttuynia cordata: A current review.

Authors:  C Laldinsangi
Journal:  Heliyon       Date:  2022-08-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.